Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'pi3 kinase p110'

Search results for: 'pi3 kinase p110'

Items 651-660 of 692

Page
per page
  1. IRAK-1-4 Inhibitor I
    A3505 IRAK-1-4 Inhibitor I
     3 Citation
    Target: IRAK
    Summary: IRAK-1/4 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.75 mg/mL
  2. CX-6258
    A3337 CX-6258
    Summary: Pan-Pim kinases Inhibitor
      insoluble in EtOH; ≥11.15 mg/mL
  3. AG-18
    A1173 AG-18
    Summary: EGFR/PDGFR inhibitor
  4. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/InsR inhibitor,potent and selective
      ≥23.05 mg/mL
  5. LRRK2-IN-1
    A3558 LRRK2-IN-1
     1 Citation
    Target: LRRK2|DCLK2
    Summary: LRRK2 inhibitor,cell-permeable and ATP competitive
      ≥28.55 mg/mL
  6. Y-27632 dihydrochloride
    A3008 Y-27632 dihydrochloride
     19 Citation
    Target: ROCK
    Summary: ROCK1 inhibitor
      ≥111.2 mg/mL
  7. QL-X-138
    BA1624 QL-X-138
    Summary: QL-X-138 is a potent and selective dual kinase inhibitor that exhibits covalent binding to and non-covalent binding to ...
  8. LP-935509
    BA2262 LP-935509
    Summary: LP-935509 is an orally potent, selective, ATP-competitive, and blood-brain barrier-crossing inhibitor of junctional protein-2-related kinase 1.
      ≥40 mg/mL
  9. BTdCPU
    BA2783 BTdCPU
    Summary: BTdCPU is a heme-regulated inhibitory kinase activator that promotes phosphorylation and induces apoptosis in (Dex)-resistant cancer cells.
  10. Rezivertinib
    BA6337 Rezivertinib
    Summary: Rezivertinib (BPI-7711) is an orally effective, highly selective and irreversible third-generation tyrosine kinase inhibitor (TKI).

Items 651-660 of 692

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways330item
  2. Kits2item
  3. Screening Library7item
  4. Peptides3item
  5. Peptides & Proteins10item
  6. Antibody44item
  7. Biochemical Reagent291item
Specificity
  1. Selective117item
Reversibility
  1. Reversible10item
  2. Irreversible3item
Target
  1. Cyclin-Dependent Kinases18item
  2. Akt1 item
  3. PI3K2item
  4. Raf4item
  5. Aurora Kinases20item
  6. CSF-1R3item
  7. FLT36item
  8. PLK2item
  9. Chk1 item
  10. Eph Receptors1 item
  11. VEGFR11item
  12. PDGFR7item
  13. c-Kit4item
  14. RET3item
  15. IRAK3item
  16. p384item
  17. PKB1 item
  18. JNK1 item
  19. Bcr-Abl5item
  20. MEK2item
  21. FGFR3item
  22. Pim4item
  23. Ribosomal s6 kinases (RSK)1 item
  24. MET2item
  25. Src9item
  26. Trk Receptors1 item
  27. STAT1 item
  28. EGFR6item
  29. ROCK3item
  30. BMP and Other Activin Receptors1 item
  31. JAK7item
  32. Syk4item
  33. DNA-PK1 item
  34. Adenosine Kinases2item
  35. PKC4item
  36. Ca2 /calmodulin-dependent protein kinases (CaMKs)4item
  37. Lyn1 item
  38. HER21 item
  39. LRRK23item
  40. Insulin and Insulin-like Receptors1 item
  41. ALK1 item
  42. ROS11 item
  43. PKG1 item
  44. PKA2item
  45. Myosin light chain kinases (MLCKs)2item
  46. CaM-KK1 item
  47. MELK1 item
  48. Clk1 item
  49. Angiotensin-Converting Enzymes (ACEs)1 item
  50. Tie-22item
  51. ATM/ATR3item
  52. CK11 item
  53. CK21 item
  54. HIPK21 item
  55. HIPK31 item
  56. P2X Receptors1 item
  57. TAK11 item
  58. Hck1 item
  59. 5-Lipoxygenases1 item
  60. Cdc2-like kinase (Clk)1 item
  61. eEF-21 item
  62. ZAP-701 item
  63. c-RET1 item
  64. p70 rsk2item
  65. VEGFR3/FLT41 item
  66. NTRK1/TRKA1 item
  67. CSF-1R/c-Fms1 item
  68. TAM kinase1 item
  69. Fyn kinase1 item
  70. AXL1 item
  71. c-Fms tyrosine kinase1 item
  72. haspin kinase1 item
  73. STK1 item
  74. Lyn kinase1 item
  75. Mer tyrosine kinase1 item
  76. Histone Acetyltransferases (HATs)1 item
  77. ITK1 item
  78. NUAK1 item
  79. DCLK21 item
  80. PTK1 item
  81. Lck1 item
  82. FGR1 item
  83. YES1 item
  84. Fyn1 item
  85. ARG1 item
  86. enoyl-acyl-carrier protein reductase1 item
  87. SK1 item
  88. ATM1 item
  89. Insulin Receptor1 item
Reported Experiments
  1. Animal Experiments119item
  2. Cell Experiments89item
Related Disease
  1. Acute Myeloid Leukemia9item
  2. Adrenocortical Carcinoma1 item
  3. Advanced Renal Cell Carcinoma1 item
  4. Bladder Cancer2item
  5. Bladder Carcinoma1 item
  6. B-lymphoid Malignancies1 item
  7. Breast Cancer23item
  8. Cancer90item
  9. Cervical Cancer2item
  10. Cholangiocarcinoma1 item
  11. Chronic Lymphocytic Leukemia1 item
  12. Colon Cancer11item
  13. Colon Carcinoma1 item
  14. Colorectal Cancer6item
  15. Glioblastoma7item
  16. Glioma4item
  17. Hepatocellular Carcinoma1 item
  18. Immunological Diseases1 item
  19. Inflammatory Bowel Disease1 item
  20. Inflammatory Diseases3item
  21. Leukemia3item
  22. Liver Cancer2item
  23. Lung Cancer6item
  24. Lung Carcinoma1 item
  25. Lymphoma6item
  26. Mantle Cell Lymphoma1 item
  27. Melanoma5item
  28. Multiple Myeloma3item
  29. Neuroblastoma1 item
  30. Non-small Cell Lung Cancer1 item
  31. Ovarian Cancer9item
  32. Pancreatic Cancer10item
  33. Prostate Cancer5item
  34. Renal Cancer1 item
  35. Renal Cell Carcinoma2item
  36. Rheumatoid Arthritis3item
  37. Thyroid Cancer5item